Bionano OGM studies at ESHG 2026 rise 67% year over year Jun 18, 2026 08:03AM
Bionano reports studies show optical genome mapping detects genetic variants in reproductive health Jun 11, 2026 08:04AM
Bionano retires $20 million convertible debt, eliminates secured obligations May 28, 2026 08:09AM
Bionano study finds genome mapping detects 97.8% of T-cell leukemia cases May 26, 2026 08:05AM
BioNano Genomics, Inc. (BNGO) files $400M mixed shelf May 8, 2026 04:09PM


May 6, 2026 04:31PM Bionano names board chairman Al Luderer as interim CEO
May 5, 2026 08:04AM Bionano reports 56% increase in rare disease publications using optical genome mapping
May 5, 2026 08:04AM Bionano reports 56% increase in rare disease publications using optical genome mapping
Apr 13, 2026 06:41AM Bionano Genomics (BNGO) PT Lowered to $6 at H.C. Wainwright
Apr 2, 2026 08:03AM Bionano study shows optical genome mapping outperforms traditional methods
Feb 4, 2026 08:00AM Bionano study shows gene editing detection capabilities
Jan 20, 2026 06:38AM H.C. Wainwright Reiterates Buy Rating on Bionano Genomics (BNGO)
Jan 12, 2026 08:07AM Bionano Genomics reports preliminary Q4 2025 revenue of $7.8-8.0 million
Nov 24, 2025 06:38AM Bionano Genomics (BNGO) PT Lowered to $7 at H.C. Wainwright
Nov 6, 2025 08:04AM Bionano study shows optical genome mapping detects more leukemia variants
Sep 17, 2025 05:00PM Bionano Genomics closes $10 million public offering with warrants
Sep 16, 2025 09:10AM Bionano Genomics prices $10 million public offering at $2 per share
Sep 15, 2025 07:01AM CMS sets $1,263.53 payment rate for Bionano optical genome mapping code
Aug 22, 2025 06:17AM BTIG Reiterates Neutral Rating on Bionano Genomics (BNGO)
Aug 18, 2025 06:49AM Bionano Genomics (BNGO) PT Raised to $11 at H.C. Wainwright
Jan 22, 2025 04:07PM BioNano Genomics, Inc. (BNGO) Sets January 24 as Effective Date of 1:60 Reverse Share Split
Jan 13, 2025 08:12AM BioNano Genomics, Inc. (BNGO) Reports Preliminary Fourth Quarter and Full-Year 2024 Results
Jan 3, 2025 04:11PM BioNano Genomics, Inc. (BNGO) Files for 50.56M Share Offering by Selling Stockholders
Jan 3, 2025 02:35PM BioNano Genomics, Inc. (BNGO) Prices 39.68M Share Offering at $0.252/sh
Dec 31, 2024 03:27PM BioNano Genomics (BNGO) Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway
Nov 18, 2024 07:25AM BTIG Reiterates Neutral Rating on Bionano Genomics (BNGO)
Nov 15, 2024 06:42AM Ladenburg Thalmann Downgrades Bionano Genomics (BNGO) to Neutral
Oct 31, 2024 08:00AM BioNano Genomics, Inc. (BNGO) Prices 9.88M Share Offering at $0.304/sh
Oct 24, 2024 08:04AM BioNano Genomics (BNGO) Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma
Oct 10, 2024 08:01AM BioNano Genomics, Inc. (BNGO) Announces Preliminary 3Q 2024 Revenues and Cash
Sep 10, 2024 06:10AM BTIG Downgrades Bionano Genomics (BNGO) to Neutral
Aug 14, 2024 05:19AM BTIG Reiterates Buy Rating on Bionano Genomics (BNGO)
Jul 31, 2024 04:32PM BioNano Genomics, Inc. (BNGO) Files for 35.02M Share Offering by Selling Stockholders
Jul 5, 2024 08:01AM BioNano Genomics, Inc. (BNGO) Announces up to $30 Million Registered Direct Offering of Common Stock, Warrants
Jun 20, 2024 08:04AM BioNano Genomics, Inc. (BNGO) Enters Marketing Agreement with Revvity (RVTY)